“Is GLP-1 Receptor Agonist Therapy Safe for Patients With Intraductal Papillary Mucinous Neoplasm?”. Swiss Medical Weekly, vol. 155, no. 10, Oct. 2025, p. 4850, https://doi.org/10.57187/s.4850.